Extraction of Short-chain Fatty Acids from Mouse Feces Using A Two-phase Acid–Solvent Method
July 17th, 2026
This protocol describes a two-phase acid–solvent extraction method for isolating short-chain fatty acids from low-input mouse fecal samples without derivatization.
This protocol enables the extraction of short-chain fatty acids or SCFAs from low input mouse fecal samples for routine gas chromatography-based analysis. SCFAs including acetate, propionate, and butyrate are produced by gut microbiota through the fermentation of dietary fiber. They're widely studied because they are associated with behavioral, metabolic, and physiological phenotypes.
However, quantifying SCFAs in fecal samples remains challenging. These metabolites are volatile, often present at low levels, and are measured in complex biological matrices. In mouse studies, the amount of fecal material collected from each animal is also often limited.
Standard methods may require derivatization, relatively large sample volumes, or specialized equipment. Here, a two-phase acid solvent extraction workflow using dilute hydrochloric acid and ethyl acetate is presented for the extraction of SCFAs from low-input mouse fecal samples in a format compatible with routine GC analysis. So we begin with our proper layout to continue with the rest of our protocol.
We next have our sample box with our frozen fecal samples correctly labeled. Next, we set our 1000 microliter pipette to 255. Now we have our labeled HCl dilution.
We continue with allocating HCl into each of our samples. Now, we put ethanol into our cleaning well for our tweezers. Now, we use the same ethanol to create our bath for our pestles.
Now, we grab our fecal samples and put them into the centrifuge vials. Now, we use our clean pestles to grind up each fecal sample within their respective centrifuge vials. We take our samples and we apply them to the vortex for at least 10 seconds or until they are completely mixed.
We bring the mixed samples to our centrifuge and set up. Ensure proper balancing of the centrifuge. Set the centrifuge to 16, 000 times g for 10 minutes at four degrees Celsius.
After 10 minutes is up, remove your samples from the centrifuge. Relabel new centrifuge vials corresponding with your samples. Set your 200 microliter pipette to 120.
Carefully remove the supernatant, making sure not to touch the pellet. Transfer the supernatant into your new respective vials. You can discard the pellet.
Add an equal amount of ethyl acetate into your new vials. Bring these samples back to the centrifuge. Set the centrifuge to 2, 374 times g for 20 minutes at four degrees Celsius.
After 20 minutes is up, remove your samples. Relabel new centrifuge vials corresponding with your samples. Set your pipette back to 120 microliters.
Careful not to touch the bottom layer, removing only the top layer. Transfer the supernatant into new vials correctly labeled. Transfer these samples to your sample box for storage until further analysis.
Lastly, place a sample box into a negative 80-degree-Celsius freezer. The extracted SCFA aliquots, 120 microliters each, were stored at negative 80 degrees Celsius before quantification using gas chromatography. Quantitative analysis identified eight SCFAs, including the key metabolites:acetic acid, propionic acid, and butyric acid as shown in the figure.
To validate SCFA isolation, gas chromatography data was assessed through recovery and reproducibility tests. Recovery was evaluated by spiking control samples with known concentrations of the internal standard, whereas reproducibility was verified by repeated analyses within and across days. In summary, this protocol provides a workflow for SCFA extraction from low-input mouse fecal samples.
It does not require derivatization and is compatible with routine GC-based analysis. This method can support fecal SCFA measurement in diverse mouse models.
View the full transcript and gain access to thousands of scientific videos
Overview
This article presents a protocol for extracting short-chain fatty acids (SCFAs) from low-input mouse fecal samples using a two-phase acid–solvent extraction method. The approach is optimized for small sample sizes and is compatible with standard laboratory equipment, enabling efficient preparation of samples for gas chromatography-based analysis.
Key Study Components
Area of Science
- Analytical chemistry
- Metabolomics
- Microbiome research
Background
- SCFAs are important microbial metabolites in the gut with significant biological roles.
- Accurate quantification of SCFAs from small fecal samples is challenging in small-animal studies.
- Existing extraction methods may require derivatization or large sample inputs.
- There is a need for standardized, efficient protocols compatible with routine analytical workflows.
Purpose of Study
- To develop a protocol for extracting SCFAs from individual mouse fecal samples of 20–50 mg.
- To enable phase separation without derivatization using dilute hydrochloric acid and ethyl acetate.
- To ensure compatibility with gas chromatography-based analysis.
Methods Used
- Fecal homogenization
- Acidification with dilute hydrochloric acid
- Organic solvent partitioning using ethyl acetate
- Low-temperature centrifugation
- Use of standard laboratory equipment
Main Results
- Successful extraction of major SCFAs (acetate, propionate, butyrate) from individual mouse fecal samples.
- Clear resolution of SCFA peaks at characteristic retention times above background noise.
- Protocol is effective for low-input samples and maintains compatibility with routine gas chromatography platforms.
Conclusions
- The protocol provides a standardized workflow for SCFA extraction from limited fecal material.
- It addresses procedural challenges in small-animal studies.
- The method supports reliable downstream SCFA analysis using common laboratory equipment.
Frequently Asked Questions
Executive Industry Relevance
Standardized extraction of short-chain fatty acids (SCFAs) from low-input mouse fecal samples addresses a critical bottleneck in microbiome-driven discovery and preclinical metabolomics. This protocol enables reliable quantification of SCFAs using routine gas chromatography, supporting translational studies that link gut microbial metabolites to host biology. The method enhances predictive confidence in early discovery and facilitates cross-study comparability for enterprise R&D portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables robust measurement of gut-derived SCFAs for hypothesis-driven microbiome research.
- Supports functional validation of microbial metabolic pathways in disease-relevant models.
- Facilitates mechanistic de-risking by providing quantitative metabolite readouts.
Screening & Assay Development
- Prepares standardized biological extracts compatible with high-throughput gas chromatography workflows.
- Improves assay reproducibility and comparability across low-input preclinical samples.
- Enables reliable screening of interventions that modulate SCFA production.
Translational & Preclinical Research
- Aligns metabolite quantification with translational biomarker strategies in small-animal models.
- Supports continuity from discovery through preclinical validation of microbiome-targeted interventions.
- Reduces risk of analytical variability in cross-study and cross-site research.
Pipeline & Workflow Integration
This extraction protocol fits within the early discovery to preclinical continuum, enabling quantitative SCFA analysis from limited biological material and supporting downstream biomarker and mechanistic studies.
- Discovery Biology: Provides a standardized workflow for hypothesis testing and pathway interrogation in microbiome research.
- Screening: Delivers reproducible, quantitative SCFA measurements suitable for assay development and compound evaluation.
- Analytics: Generates clear chromatographic peaks for comparative analysis of experimental conditions.
- Translational Research: Facilitates alignment of preclinical metabolite data with translational biomarker objectives.
- Enterprise Reuse: Offers a broadly applicable extraction method for diverse microbiome and metabolomics studies.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in microbiome-metabolite relationships and target validation.
- Operational Value: Standardizes extraction and analysis across studies, improving reproducibility and scalability.
- Strategic Value: Enables informed go/no-go decisions for microbiome-targeted programs and reduces late-stage analytical risk.
- Portfolio Impact: Supports risk-adjusted prioritization of microbiome and metabolite-driven discovery assets.
Implementation Considerations
- Requires expertise in sample homogenization and gas chromatography analysis.
- Utilizes standard laboratory equipment and routine analytical infrastructure.
- Demands cross-team adherence to standardized extraction and analysis protocols.
- Adaptable to various small-animal models and limited sample inputs.
- Extraction efficiency and detection limits should be validated for each experimental context.
